Back
Protalix BioTherapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
22
PLX
Protalix BioTherapeutics
Last Price:
$1.72
Seasonality Move:
0.45%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
Protalix BioTherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.76 | Sell |
| 20-day SMA: | 2.73 | Sell |
| 50-day SMA: | 2.53 | Sell |
| 200-day SMA: | 1.77 | Sell |
| 8-day EMA: | 2.61 | Sell |
| 20-day EMA: | 2.68 | Sell |
| 50-day EMA: | 2.57 | Sell |
| 200-day EMA: | 2.02 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 27.24 | Sell |
| Chaikin Money Flow: | -5944496 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.96) | Sell |
| Bollinger Bands (100): | (2.05 - 2.71) | Sell |
Protalix BioTherapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.72 while PLX 8-day simple moving average is 2.76, which is a Sell signal.
-
The stock price of PLX is 1.72 while Protalix BioTherapeutics 20-day SMA is 2.73, which makes it a Sell.
-
Protalix BioTherapeutics 50-day simple moving average is 2.53 while PLX share price is 1.72, making it a Sell technically.
-
PLX stock price is 1.72 and Protalix BioTherapeutics 200-day simple moving average is 1.77, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
22
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a SellThe current Protalix BioTherapeutics [PLX] share price is $1.72. The Score for PLX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
134.2M
Price in USD:
1.72
Share Volume:
5.9M
Protalix BioTherapeutics 52-Week Range
52-Week High:
3.10
52-Week Low:
0.82
Sell
22
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 1.72 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 1.72 while PLX 8-day exponential moving average is 2.61, which is a Sell signal.
-
The stock price of PLX is 1.72 while Protalix BioTherapeutics 20-day EMA is 2.68, which makes it a Sell.
-
Protalix BioTherapeutics 50-day exponential moving average is 2.57 while PLX share price is 1.72, making it a Sell technically.
-
PLX stock price is 1.72 and Protalix BioTherapeutics 200-day simple moving average is 2.02, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Protalix BioTherapeutics is a Buy
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 27.24, which suggest Protalix BioTherapeutics is oversold
-
The Bollinger Bands (25) for Protalix BioTherapeutics is (2.34 - 2.96), which suggest Protalix BioTherapeutics is a Sell
-
The Bollinger Bands (100) for Protalix BioTherapeutics is (2.05 - 2.71), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.